Half a million at-home COVID-19 tests sold at CVS may be contaminated with bacteria, FDA says

United States News News

Half a million at-home COVID-19 tests sold at CVS may be contaminated with bacteria, FDA says
United States Latest News,United States Headlines
  • 📰 PennLive
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 53%

The SD Biosensor Pilot tests were recalled by Roche Diagnostics.

The U.S. Food and Drug Administration on May 4, 2023, issued a safety warning about the SD Biosensor Pilot at-home COVID-19 tests saying it has "significant concerns of bacterial contamination" of the liquid in the test solution. More than a half a million COVID-19 at-home test kits distributed to CVS Health and on Amazon should not be used because the liquid in the test tubes may be contaminated, according to the FDA.

The FDA said it has “significant concerns of bacterial contamination in the Pilot COVID-19 At-Home Test liquid solution, provided in the test kit.” Not only could a person using the test come in direct contact with the bacteria, the FDA said the contamination also can have an impact on the “performance of the test.”

The FDA said, the liquid in the test tube “has been found to be contaminated with organisms such as Enterococcus, Enterobacter, Klebsiella and Serratia species.”“The FDA is continuing to work with SD Biosensor Inc. to assess the company’s corrective actions to address the reason for bacterial contamination and help ensure the situation is resolved and will not return.”

SD Biosensor has recalled the tests. The FDA said about 500,000 of the tests were distributed to CVS Health and another 16,000 to Amazon.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

PennLive /  🏆 463. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CVS Health to pause M&A and focus on integrationCVS Health to pause M&A and focus on integrationCVS Health Corp said on Wednesday it would pause its recent acquisition spree as it focuses on integrating purchases of healthcare service provider Signify Health and primary care provider Oak Street Health.
Read more »

CVS Posts Higher Revenue as It Closes AcquisitionsCVS Posts Higher Revenue as It Closes AcquisitionsCVS earnings for the first quarter provided the first look at the prospects and challenges confronting the healthcare company as it takes on a bigger role in treating patients
Read more »

FDA Does Not Require Menstrual Product Ingredients on LabelsFDA Does Not Require Menstrual Product Ingredients on LabelsNew York and California have passed laws requiring disclosure of ingredients on menstrual product packaging. Advocates want more transparency across the United States.
Read more »

FDA approves world's first RSV vaccine, a shot for adults ages 60 and upFDA approves world's first RSV vaccine, a shot for adults ages 60 and upBREAKING: FDA approves the world's first respiratory syncytial virus, or RSV, vaccine made by pharmaceutical giant GSK.
Read more »

FDA approves first vaccine for RSV, a moment six decades in the making | CNNFDA approves first vaccine for RSV, a moment six decades in the making | CNNAfter a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.
Read more »



Render Time: 2025-02-22 04:08:16